Mefloquine Hydrochloride Tablets
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
DOWNLOAD PDF HERE
1 DEFINITION
Mefloquine Hydrochloride Tablets contain NLT 90.0% and NMT 110.0% of the labeled amount of mefloquine hydrochloride (C17H16F6N2O · HCl).
2 IDENTIFICATION
A. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
Change to read:
B. Spectroscopic Identification Tests 〈197〉, Ultraviolet-Visible Spectroscopy: 197U (CN 1-May-2020)
Diluent, Standard solution, and Sample solution: Proceed as directed in the Assay.
Blank: Diluent
3 ASSAY
Procedure
Buffer: 2.7 g/L of monobasic potassium phosphate. Adjust with phosphoric acid to a pH of 3.0 ± 0.1.
Diluent: Methanol and water (23:27)
Mobile phase: Methanol, acetonitrile, and Buffer (13:10:27)
Standard solution: 0.05 mg/mL of USP Mefloquine Hydrochloride RS in Diluent
Sensitivity solution: 0.025 μg/mL of USP Mefloquine Hydrochloride RS in Diluent
Sample stock solution: Transfer a suitable number of Tablets to a volumetric flask, dilute with methanol (approximately 80% of the total volume), shake for 30 min, allow to sit for 1 h, and dilute with methanol to volume to obtain a solution having a concentration of 2.5 mg/mL of mefloquine hydrochloride.
Sample solution: Nominally 0.05 mg/mL of mefloquine hydrochloride in Diluent from the Sample stock solution
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 222 nm
Column: 4.6-mm × 15-cm; 5-μm packing L68
Flow rate: 1 mL/min
Injection size: 10 μL
System suitability
Samples: Standard solution and Sensitivity solution
Suitability requirements
Column efficiency: NLT 4000 theoretical plates, Standard solution
Tailing factor: NMT 1.5, Standard solution
Signal-to-noise ratio: NLT 5, Sensitivity solution
Relative standard deviation: NMT 2.0%, Standard solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of mefloquine hydrochloride (C17H16F6N2O · HCl) in the portion of Tablets taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response from the Sample solution
rS = peak response from the Standard solution
CS = concentration of USP Mefloquine Hydrochloride RS in the Standard solution (mg/mL)
CU = nominal concentration of mefloquine hydrochloride in the Sample solution (mg/mL)
Acceptance criteria: 90.0%–110.0%
4 PERFORMANCE TESTS
Dissolution 〈711〉
Test 1
Medium: 0.1 N hydrochloric acid; 900 mL
Apparatus 2: 50 rpm
Time: 30 min
Standard stock solution: 0.2 mg/mL of USP Mefloquine Hydrochloride RS in Medium. A small amount of methanol, not exceeding 5% of the final volume, may be used to help solubilize mefloquine.
Standard solution: 0.04 mg/mL of USP Mefloquine Hydrochloride RS in Medium from the Standard stock solution
Sample solution: Dilute a portion of the solution under test with Medium (1:5), and pass a portion through a suitable filter of 0.8-μm pore size.
Instrumental conditions
(See Ultraviolet-Visible Spectroscopy 〈857〉.)
Mode: UV
Analytical wavelength: 285 nm
Cell length: 1 cm
Blank: Medium
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of mefloquine hydrochloride (C17H16F6N2O · HCl) dissolved:
Result = (AU /AS ) × (CS /L) × D × V × 100
AU= absorbance from the Sample solution
AS = absorbance from the Standard solution
CS = concentration of USP Mefloquine Hydrochloride RS in the Standard solution (mg/mL)
L = label claim (mg/Tablet)
D = dilution factor of the Sample solution
V = volume of Medium, 900 mL
Tolerances: NLT 80% (Q) of the labeled amount of mefloquine hydrochloride (C17H16F6N2O · HCl) is dissolved.
Test 2: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 2.
Medium: 0.01 N hydrochloric acid; 900 mL
Apparatus 2: 50 rpm
Time: 30 min
Standard solution: 0.278 mg/mL of USP Mefloquine Hydrochloride RS in Medium. A small amount of methanol, not exceeding 2.5% of the final volume, may be used to help solubilize mefloquine.
Sample solution: Pass a portion of the solution under test through a suitable filter.
Instrumental conditions
(See Ultraviolet-Visible Spectroscopy 〈857〉.)
Mode: UV
Analytical wavelength: 284 nm
Cell length: 0.2 cm
Blank: Medium
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of mefloquine hydrochloride (C17H16F6N2O · HCl) dissolved:
Result = (AU /AS) × (CS /L) × V × 100
AU = absorbance from the Sample solution
AS = absorbance from the Standard solution
CS = concentration of USP Mefloquine Hydrochloride RS in the Standard solution (mg/mL)
L = label claim (mg/Tablet)
V = volume of Medium, 900 mL
Tolerances: NLT 75% (Q) of the labeled amount of mefloquine hydrochloride (C17H16F6N2O · HCl) is dissolved.
Uniformity of Dosage Units 〈905〉: Meet the requirements
5 IMPURITIES
Organic Impurities
Buffer, Diluent, Mobile phase, Standard solution, Sensitivity solution, Sample stock solution, Sample solution, Chromatographic system, and System suitability: Proceed as directed in the Assay.
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of each impurity in the portion of Tablets taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response of each impurity from the Sample solution
rS = peak response of mefloquine hydrochloride from the Standard solution
CS = concentration of USP Mefloquine Hydrochloride RS in the Standard solution (mg/mL)
CU = nominal concentration of mefloquine hydrochloride in the Sample solution (mg/mL)
Acceptance criteria: See Table 1.
[Note—Do not include the threo isomer, a process impurity monitored in the drug substance, in the calculation of total impurities. Disregard any peak less than 0.05%.]
Table 1
| Name | Relative Retention Time | Acceptance Criteria, NMT (%) |
| Specified (unidentified) | 0.67 | 0.15 |
| Specified (unidentified) | 0.70 | 0.15 |
| threo-Mefloquine (dl-threo-α-2-piperidyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol) | 0.75 | - |
| Specified (unidentified) | 0.84 | 0.25 |
| Mefloquine hydrochloride | 1.0 | - |
| Any other unknown individual impurity | - | 0.15 |
| Total impurities | - | 0.50 |
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in tight, light-resistant containers. Store at controlled room temperature.
Labeling: When more than one Dissolution test is given, the labeling states the Dissolution test used only if Test 1 is not used.
USP Reference Standards 〈11〉
USP Mefloquine Hydrochloride RS

